Wordt geladen...
Phase I and Pharmacokinetic Study of Paclitaxel by 24‐Hour Intravenous Infusion
Paclitaxel, a new antitubular agent, appears to be one of the most promising single agents for the chemotherapy of various solid tumors. The primary objectives of this phase I study of paclitaxel using 24‐h continuous intravenous infusions were to determine the maximum tolerated dose of paclitaxel a...
Bewaard in:
| Gepubliceerd in: | Jpn J Cancer Res |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Blackwell Publishing Ltd
1994
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5919347/ https://ncbi.nlm.nih.gov/pubmed/7961108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.1994.tb02906.x |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|